Salzhauer Michael’s Vir Biotechnology VIR Stock Holding History

Salzhauer Michael’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,600	Closed	-$2.49K	–	100
2025 Q3	$2.49K	Buy	+8,600	New	+$44K	﹤0.01%	93

Other funds holding VIR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Salzhauer Michael's VIR Position: Q4 2025 in Review

Salzhauer Michael sold out of Vir Biotechnology (VIR) in Q4 2025, closing a stake of 4,300 shares — an estimated $262K sold.

Salzhauer Michael first reported a position in VIR in Q3 2025 and held it in 1 quarter. The position peaked at $262K in Q3 2025. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

Salzhauer Michael reported no remaining Vir Biotechnology position as of Q4 2025 after selling out during the quarter.
Salzhauer Michael sold 4,300 Vir Biotechnology shares in Q4 2025, an estimated $262K.
Salzhauer Michael first reported a position in Vir Biotechnology in Q3 2025 and held it in 1 quarter.
Salzhauer Michael's Vir Biotechnology position peaked at $262K in Q3 2025.
218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on Salzhauer Michael's 13F filing for Q4 2025, filed 2 Feb 2026.